{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:24:56Z","timestamp":1775323496617,"version":"3.50.1"},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T00:00:00Z","timestamp":1421884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We evaluated the influence of kidney volume (<jats:styled-content style=\"fixed-case\">KV<\/jats:styled-content>) and liver volume (<jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>) on continuation of peritoneal dialysis (<jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>) in patients with autosomal dominant polycystic kidney disease (<jats:styled-content style=\"fixed-case\">PKD<\/jats:styled-content>). Twenty\u2010two <jats:styled-content style=\"fixed-case\">PKD<\/jats:styled-content> patients on <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> were retrospectively investigated after being divided into two groups. Group 1 comprised 15 patients who started <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> at our hospital and group 2 was composed of seven patients referred from other hospitals for treatment of renomegaly by transcatheter arterial embolization (<jats:styled-content style=\"fixed-case\">TAE<\/jats:styled-content>) at 47.1\u2009\u00b1\u200921.8 months after commencing <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>. In group 1, <jats:styled-content style=\"fixed-case\">KV<\/jats:styled-content> for both kidneys (mean\u2009\u00b1\u2009<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>) was 2787\u2009\u00b1\u20091945\u2009mL (range: 1043 to 6816\u2009mL), <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> was 2198\u2009\u00b1\u20091139\u2009mL (1005 to 4116\u2009mL), and the total organ volume (<jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content>\u2009=\u2009<jats:styled-content style=\"fixed-case\">KV<\/jats:styled-content>\u2009+\u2009<jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>) was 4985\u2009\u00b1\u20091815\u2009mL (2320 to 8912\u2009mL). In the patient with the largest <jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content> from group 1 (<jats:styled-content style=\"fixed-case\">KV<\/jats:styled-content> of 6816\u2009mL, <jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content> of 8912\u2009mL, and <jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content> ratio of 426, <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> was stopped due to dialysate leakage. However, dialysate leakage did not occur in the other 14 patients (<jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content>\u2009\u2266\u20097963\u2009mL and <jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content> ratio of 353 at the start of <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>). In group 2, <jats:styled-content style=\"fixed-case\">KV<\/jats:styled-content> was 5822\u2009\u00b1\u20091597\u2009mL (3832 to 8862\u2009mL), <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> was 1776\u2009\u00b1\u2009519\u2009mL (1271 to 2671\u2009mL), and <jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content> was 7597\u2009\u00b1\u20091431\u2009mL (5505 to 10358) before <jats:styled-content style=\"fixed-case\">TAE<\/jats:styled-content>. Leakage of dialysate did not occur with a mean infusion volume of 1530\u2009\u00b1\u2009370\u2009mL (1000\u2009mL to 2000\u2009mL), even after renomegaly and hepatomegaly progressed to the maximum <jats:styled-content style=\"fixed-case\">TV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BMI<\/jats:styled-content> ratio of 359. Six patients from the two groups developed new abdominal hernias at 36\u2009\u00b1\u20095 months (6\u201355 months) after starting <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>. These findings suggest that performance of <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content> may be limited by renomegaly and hepatomegaly in patients with <jats:styled-content style=\"fixed-case\">PKD<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/1744-9987.12272","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T07:40:55Z","timestamp":1421912455000},"page":"207-211","source":"Crossref","is-referenced-by-count":12,"title":["Peritoneal Dialysis is Limited by Kidney and Liver Volume in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1111","volume":"19","author":[{"given":"Satoshi","family":"Hamanoue","sequence":"first","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Marui","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ueno","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hazue","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Mise","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kawada","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Imafuku","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hayami","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Sumida","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennmei","family":"Takaichi","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"},{"name":"Okinaka Memorial Institute for Medical Research Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Nephrology Center Toranomon Hospital  Tokyo Japan"},{"name":"Okinaka Memorial Institute for Medical Research Toranomon Hospital  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,1,22]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.31407"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2006.00386.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.03.018"},{"key":"e_1_2_8_5_1","first-page":"832","article-title":"Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease","volume":"9","author":"Fletcher S","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/089686080202200113","article-title":"Polycystic kidney disease and late peritoneal leakage in CAPD: are they related?","volume":"22","author":"De Vecchi AF","year":"2003","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/089686080302300306","article-title":"Risk factors for abdominal wall complications in peritoneal dialysis patients","volume":"23","author":"Del Pesco G","year":"2003","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_8_1","first-page":"491","article-title":"Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis","volume":"99","author":"Graham AN","year":"1986","journal-title":"N Z Med J"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000186213"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/089686089801800414","article-title":"CAPD in patients with autosomal dominant polycystic kidney disease","volume":"18","author":"Hadimeri H","year":"1998","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.01.019"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.352"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.07.008"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1744-9987.12272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1744-9987.12272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:18:33Z","timestamp":1695572313000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1744-9987.12272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,22]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1111\/1744-9987.12272"],"URL":"https:\/\/doi.org\/10.1111\/1744-9987.12272","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,22]]}}}